Artal Group S.A. Evelo Biosciences, Inc. Transaction History

Artal Group S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.66 - $6.63 $2.66 Million - $6.63 Million	-1,000,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$9.71 - $18.6 $2.91 Million - $5.58 Million	300,000 Added 42.86%	1,000,000 $10.7 Million
Q4 2020 Feb 11, 2021	BUY	$3.91 - $12.28 $879,750 - $2.76 Million	225,000 Added 47.37%	700,000 $8.46 Million
Q3 2020 Nov 13, 2020	SELL	$3.81 - $5.73 $730,247 - $1.1 Million	-191,666 Reduced 28.75%	475,000 $2.5 Million
Q2 2020 Aug 14, 2020	BUY	$3.53 - $6.12 $2.35 Million - $4.08 Million	666,666 New	666,666 $3.27 Million

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Market Cap $6.48M
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.